Sanofi CEO on AI's Impact, Lung Disease Drug Clearance

Sanofi CEO Paul Hudson joins Caroline Hyde to discuss the company's integration of AI tools in everyday operations, the impact of AI on the biopharma sector, and the company's Dupixent drug getting cleared for a chronic lung disorder in the European Union, creating another avenue of growth for the blockbuster drug. He speaks on "Bloomberg Technology."
--------
Like this video? Subscribe to Bloomberg Technology on YouTube:
   / @bloombergtechnology  
 
Watch the latest full episodes of "Bloomberg Technology" with Caroline Hyde and Ed Ludlow here:
   • Bloomberg Technology With Caroline Hy...  
 
Get the latest in tech from Silicon Valley and around the world here:
https://www.bloomberg.com/technology
Connect with us on...
X:   / technology  
Facebook:   / bloombergtechnology  
Instagram:   / bloombergbusiness  
 
Follow Ed Ludlow on X here:   / edludlow  
Follow Caroline Hyde on X here:   / carolinehydetv  
 
Listen to the daily Bloomberg Technology podcast here:
https://www.bloomberg.com/podcasts/se...
 
More from Bloomberg Business
Connect with us on...
X:   / business  
Facebook:   / bloombergbusiness  
Instagram:   / bloombergbusiness  
LinkedIn:   / bloomberg-news  
TikTok:   / bloombergbusiness